Topical Calcineurin Inhibitors: Abstract Reference Information
Additional Reference information:
Abstract: “Changes in Topical Calcineurin Use Following Regulatory Action in the US.”
David Money, R.Ph., Lois La Grenade, M.D., M.P.H., and Allen Brinker, M.D., M.S.
U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD.